Literature DB >> 10604862

Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids.

W B Anderson1, P G Board, B Gargano, M W Anders.   

Abstract

Dichloroacetic acid (DCA) is a contaminant of chlorinated drinking water supplies, is carcinogenic in rats and mice, and is a therapeutic agent used for the treatment of congenital lactic acidosis. The biotransformation of DCA to glyoxylic acid is catalyzed by glutathione transferase zeta (GSTZ). Treatment of rats and human subjects with DCA increases its plasma elimination half-life and reduces the extent of DCA biotransformation in rat hepatic cytosol. In the investigation presented here, the kinetics of the DCA-induced inactivation of GSTZ, the turnover of GSTZ, and the susceptibility of GSTZ to inactivation by a panel of alpha-haloacids were studied. DCA rapidly inactivated GSTZ in both rat hepatic cytosol and intact Fischer 344 rats. The time course of inactivation in vivo was mirrored by a concomitant loss of immunoreactive GSTZ protein. The turnover of GSTZ in rat liver was 0.21 day(-1), which corresponded to a half-life of 3.3 days. The degree of GSTZ inactivation after daily administration of DCA could be predicted from the amount of inactivation after a single treatment. Other fluorine-lacking dihaloacetic acids also inactivated GSTZ, whereas alpha-monohaloacids and fluorine-containing dihaloacetic acids failed to inactivate GSTZ. These data show that the observed DCA-induced decrease in the level of DCA metabolism is caused by the inactivation of GSTZ.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604862     DOI: 10.1021/tx990085l

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  18 in total

1.  Identification, characterization and structure of a new Delta class glutathione transferase isoenzyme.

Authors:  Rungrutai Udomsinprasert; Saengtong Pongjaroenkit; Jantana Wongsantichon; Aaron J Oakley; La-aied Prapanthadara; Matthew C J Wilce; Albert J Ketterman
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

Review 2.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

3.  Effects of chlorinated acetates on the glutathione metabolism and on glycolysis of cultured astrocytes.

Authors:  Maike M Schmidt; Astrid Rohwedder; Ralf Dringen
Journal:  Neurotox Res       Date:  2010-07-14       Impact factor: 3.911

4.  Preliminary X-ray crystallographic analysis of glutathione transferase zeta 1 (GSTZ1a-1a).

Authors:  Christopher D Boone; Guo Zhong; Marci Smeltz; Margaret O James; Robert McKenna
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-01-21       Impact factor: 1.056

5.  The influence of human GSTZ1 gene haplotype variations on GSTZ1 expression.

Authors:  Taimour Y Langaee; Guo Zhong; Wenjun Li; Issam Hamadeh; Mohamed Hassan M Solayman; Caitrin W McDonough; Peter W Stacpoole; Margaret O James
Journal:  Pharmacogenet Genomics       Date:  2015-05       Impact factor: 2.089

6.  The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine--both or neither?

Authors:  Peter W Stacpoole
Journal:  Environ Health Perspect       Date:  2010-10-04       Impact factor: 9.031

7.  Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.

Authors:  Cindy E L Lim; Klaus I Matthaei; Anneke C Blackburn; Richard P Davis; Jane E Dahlstrom; Mark E Koina; M W Anders; Philip G Board
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Clarification of the role of key active site residues of glutathione transferase zeta/maleylacetoacetate isomerase by a new spectrophotometric technique.

Authors:  Philip G Board; Matthew C Taylor; Marjorie Coggan; Michael W Parker; Hoffman B Lantum; M W Anders
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

9.  Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.

Authors:  Edwin J Squirewell; Marci G Smeltz; Laura Rowland-Faux; Lloyd P Horne; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-09-01       Impact factor: 3.922

Review 10.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.